Routine PCR screening of blood

被引：5

作者：

Barin, F ^{[1
]}

机构：

[1] CHU Bretonneau, Virol Lab, F-37044 Tours, France

来源：

LANCET | 1999年 / 353卷 / 9166期

关键词：

D O I：

10.1016/S0140-6736(05)75901-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1799 / 1799

页数：1

相关论文

共 5 条

[1] BUSCH MP, 1997, APPL MOL BIOL BLOOD, P123
[2] The incidence window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection
Kleinman, S
Busch, MP
Korelitz, JJ
Schreiber, GB
[J]. TRANSFUSION MEDICINE REVIEWS, 1997, 11 (03) : 155 - 172
[3] Prevalence of HIV, HTLV, HBV and HVC in blood donors in France, 1992-1996
Pillonel, J
Saura, C
Courouce, AM
[J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1998, 5 (05) : 305 - 312
[4] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Poynard, T
Marcellin, P
Lee, SS
Niederau, C
Minuk, GS
Ideo, G
Bain, V
Heathcote, J
Zeuzem, S
Trepo, C
Albrecht, J
[J]. LANCET, 1998, 352 (9138) : 1426 - 1432
[5] Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
Roth, WK
Weber, M
Seifried, E
[J]. LANCET, 1999, 353 (9150) : 359 - 363